CARL ZEISS MEDITEC revenue for the last year amounted to 2.02 B CHF, the most of which — 1.53 B CHF — came from its highest performing source at the moment, Ophthalmology, the year earlier bringing 1.42 B CHF. The greatest contribution to the revenue figure was made by Asia Pacific — last year it brought CARL ZEISS MEDITEC 968.51 M CHF, and the year before that — 926.43 M CHF.